Manufacturer record
Logos Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Logos Pharma (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LGQ01/199/01, Rabeprazole Sodium (EC) & Domperidone (SR) Capsules (exp Jun 2027). VARANASI, Uttar Pradesh (state lab) found it not of standard quality: The sample does not conform to declared formula in respect of content of Rabeprazole and Domperidone. Listed in the September 2026 alert.
Records by type
6 records linked to Logos Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Rabeprazole Sodium (EC) & Domperidone (SR) Capsules | Batch LGQ01/199/01Mfg Jan 2026 · Exp Jun 2027 | The sample does not conform to declared formula in respect of content of Rabeprazole and Domperidone.Other | VARANASI, Uttar PradeshState lab | Sep 2026 |
| Levocetirizine Dihydrochloride & Montelukast Tablets IP | Batch LGP12/303/37Mfg Dec 2025 · Exp Nov 2027 | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab | Sep 2026 |
| Glimepiride & Metformin Hydrochloride Prolonged Release Tablet I.P. | Batch LGN03/133 /01Mfg Mar 2024 · Exp Feb 2026 | The sample does not conform to I.P. as per Assay result of Glimepride.Assay | SDTL, Kolkata, WBState lab | Feb 2026 |
| Glitel M2 (Glimepride & Metformin Hydrochloride Prolonged Releasre Tablets IP) | Batch LGM09/ 237/11Mfg Sep 2024 · Exp Aug 2025 | The sample does not conform to Standard in respect of the tests for ?Assay, Dissolution & Uniformity of content for Glimepiride? performed.Assay | SDTL Agartala, TripuraState lab | Feb 2025 |
| Glitel M1 (Glimepride & Metformin Hydrochloride Prolonged Releasre Tablets IP) | Batch LGN05/ 186/08Mfg May 2024 · Exp Apr 2026 | The sample does not conform to Standard in respect of the tests for ?Assay, Dissolution & Uniformity of content for Glimepiride? performed.Assay | SDTL Agartala, TripuraState lab | Feb 2025 |
| Itraconazole Capsules BP. (ITROX- 200) | Batch LGL07/150/ 20Mfg Jul 2022 · Exp Jun 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.